Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HCV Recurrence”

63 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 63 results

Not applicableActive Not RecruitingNCT04156945
What this trial is testing

Interventions to Curb Hepatitis C Reinfections Among Men Who Have Sex With Men

Who this might be right for
Hepatitis C Virus Infection
Public Health Service of Amsterdam 258
Testing effectiveness (Phase 2)Ended earlyNCT00582738
What this trial is testing

Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection

Who this might be right for
Recurrent Hepatitis C
Novartis Pharmaceuticals 43
Not applicableStudy completedNCT03197155
What this trial is testing

Direct-acting Antivirals and Hepatocellular Carcinoma Recurrence

Who this might be right for
Hepatocellular CarcinomaHepatitis CDirect Acting Antivirals
Hospices Civils de Lyon 68
Large-scale testing (Phase 3)Study completedNCT01707849
What this trial is testing

The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver Transplantation

Who this might be right for
Hepatitis C Recurrence After Liver Transplant
Hospital Vall d'Hebron 18
Testing effectiveness (Phase 2)Study completedNCT02165189
What this trial is testing

An Efficacy and Safety Study of Simeprevir and Sofosbuvir With and Without Ribavirin in Participants With Recurrent Genotype 1 Hepatitis C Post-Orthotopic Liver Transplant

Who this might be right for
Hepatitits C
Janssen Scientific Affairs, LLC 46
Not applicableStudy completedNCT03707080
What this trial is testing

Direct Acting Antiviral-Post Authorization Safety Study

Who this might be right for
Hepatitis CHepatocellular Carcinoma
Target PharmaSolutions, Inc. 42
Large-scale testing (Phase 3)Study completedNCT01640808
What this trial is testing

Study of Peretinoin for Suppressing Recurrence of HCV-positive HCC

Who this might be right for
Hepatic Neoplasm Malignant Recurrent
Kowa Company, Ltd. 616
Post-approval studies (Phase 4)Study completedNCT04695769
What this trial is testing

Combined Ribavirin With Sofosbuvir/Velpatasvir/Voxilaprevir in Retreatment of Chronic Hepatitis C Non-responders

Who this might be right for
Chronic Hepatitis C
Helwan University 281
Post-approval studies (Phase 4)Ended earlyNCT01592006
What this trial is testing

Pegylated Interferon, Ribavirin, Telaprevir in Hepatitis C Virus Infection in Orthotopic Liver Transplant Recipients

Who this might be right for
Hepatitis C
University of Chicago 3
Not applicableUnknownNCT01473849
What this trial is testing

Impact of Cytomegalovirus (CMV) Replication Over Hepatitis C Recurrence in Liver Transplant Recipients

Who this might be right for
Cytomegalovirus InfectionHepatitis C
Sociedad Española de Trasplante Hepático 179
Testing effectiveness (Phase 2)Study completedNCT01121731
What this trial is testing

A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C Virus InfectionGenotype 1Treatment-Experienced Patients+1 more
Digna Biotech S.L. 70
Testing effectiveness (Phase 2)Study completedNCT01559844
What this trial is testing

Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant

Who this might be right for
Hepatitis CHepatocellular Carcinoma
Gilead Sciences 61
Not applicableUnknownNCT00701272
What this trial is testing

FGL2/Fibroleukin and Hepatitis C Virus Recurrence Post Liver Transplantation

Who this might be right for
Liver TransplantationHepatitis C
University Health Network, Toronto 70
Post-approval studies (Phase 4)Study completedNCT03133065
What this trial is testing

Early Treatment of Recurrent HCV- Infection Post Liver Transplantation in the Era of DAAs

Who this might be right for
Liver Transplantation
Ain Shams University 89
Post-approval studies (Phase 4)Study completedNCT00087633
What this trial is testing

PHOENIX Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) Administered After Liver Transplantation for Hepatitis C.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 115
Early research (Phase 1)Study completedNCT02143401
What this trial is testing

Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
CirrhosisHepatitis B InfectionHepatitis C Infection+6 more
National Cancer Institute (NCI) 29
Large-scale testing (Phase 3)Study completedNCT00151580
What this trial is testing

Treatment of Recurrent Hepatitis C After Liver Transplantation

Who this might be right for
Liver TransplantationHepatitis C
Rennes University Hospital 200
Not applicableApproved For MarketingNCT01779518
What this trial is testing

Expanded Access Program of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon in Aggressive Post-transplant Hepatitis C

Who this might be right for
Post-transplant Hepatitis C
Gilead Sciences
Large-scale testing (Phase 3)UnknownNCT03551444
What this trial is testing

Recurrence Rate of Hepatocellular Carcinoma After Treatment of Chronic Hepatits C Patients With Direct Acting Antivirals: Randomized Controlled Phase 3 Trial

Who this might be right for
Hepatocellular CarcinomaHepatitis C, Chronic
Ain Shams University 80
Post-approval studies (Phase 4)Study completedNCT01134952
What this trial is testing

Study of Sirolimus Versus Mycophenolate Liver Transplant Recipients With Recurrent Hepatitis C Virus (HCV)

Who this might be right for
Hepatitis C
London Health Sciences Centre 11
Load More Results